Latest News

Amarin loses legal fight over heart drug patent; shares sink

Amarin shares fell sharply Monday evening after a federal judge ruled that key patents covering its heart drug Vascepa were invalid.

The decision is a victory for two drug makers, Hikma Pharmaceuticals and Dr. Reddy’s Laboratories, seeking to make and sell generic versions of Vascepa.

Read the rest…

Source link

Related posts

The impact of the Prevent Duty on schools: a review of the evidence


New study may lead to better treatments for Parkinson's disease


Global Nurse Call Systems Market to Exceed $2.9 Billion by 2027 – Forecast Analysis by Equipment, Technology, Application, End-user and Geography –


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy